Sfoglia per Autore
Fitting late rectal bleeding data using different NTCP models : Results from an Italian multi-centric study (AIROPROS0101)
2004 T. Rancati, C. Fiorino, G. Gagliardi, G.M. Cattaneo, G. Sanguineti, V.C. Borca, C. Cozzarini, G. Fellin, F. Foppiano, G. Girelli, L. Menegotti, A. Piazzolla, V. Vavassori, R. Valdagni
Is the alpha-beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy
2005 R. Valdagni, C. Italia, P. Montanaro, A. Lanceni, P. Lattuada, T. Magnani, C. Fiorino, A. Nahum
Fractionation and late rectal toxicity: No reliable estimates of α/β value for rectum can be derived from studies where different volumes of rectum are irradiated at different dose levels: In regard to Brenner [1] (multiple letters)
2005 C. Fiorino, G. Sanguineti, R. Valdagni, D.J. Brenner
In regard to Kagan: "The multidisciplinary clinic" (Int J Radiat Oncol Biol Phys 2005;61:967-968) [3]
2005 R. Valdagni, R. Salvioni, N. Nicolai, S. Villa, N. Bedini, E. Bajetta, G. Procopio, S. Donegani, M. Bosisio
Cancer of the prostate
2005 S. Bracarda, O. De Cobelli, C. Greco, T. Prayer Galetti, R. Valdagni, G. Gatta, F. de Braud, G. Bartsch
Emptying the rectum before treatment delivery limits the variations of rectal dose-volume parameters during 3DCRT of prostate cancer
2006 M. Stasi, F. Munoz, C. Fiorino, M. Pasquino, B. Baiotto, P. Marini, G. Malinverni, R. Valdagni, P. Gabriele
Predictors for Rectal and Intestinal Acute Toxicities During Prostate Cancer High-Dose 3D-CRT : Results of a Prospective Multicenter Study
2007 V. Vavassori, C. Fiorino, T. Rancati, A. Magli, G. Fellin, M. Baccolini, C. Bianchi, E. Cagna, F.A. Mauro, A.F. Monti, F. Munoz, M. Stasi, P. Franzone, R. Valdagni
Vaccination therapy in prostate cancer
2007 A. Marrari, M. Iero, L. Pilla, S. Villa, R. Salvioni, R. Valdagni, G. Parmiani, L. Rivoltini
Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy : Planning data and toxicity results of a Phase I-II study
2008 C. Cozzarini, C. Fiorino, N. Di Muzio, R. Valdagni, A. Salonia, F. Alongi, S. Broggi, G. Guazzoni, F. Montorsi, P. Rigatti, R. Calandrino, F. Fazio
Evidence of Limited Motion of the Prostate by Carefully Emptying the Rectum as Assessed by Daily MVCT Image Guidance with Helical Tomotherapy
2008 C. Fiorino, N. Di Muzio, S. Broggi, C. Cozzarini, E. Maggiulli, F. Alongi, R. Valdagni, F. Fazio, R. Calandrino
Development of a Set of Nomograms to Predict Acute Lower Gastrointestinal Toxicity for Prostate Cancer 3D-CRT
2008 R. Valdagni, T. Rancati, C. Fiorino, G. Fellin, A. Magli, M. Baccolini, C. Bianchi, E. Cagna, C. Greco, F.A. Mauro, A.F. Monti, F. Munoz, M. Stasi, P. Franzone, V. Vavassori
Physics aspects of prostate tomotherapy : Planning optimization and image-guidance issues
2008 C. Fiorino, F. Alongi, S. Broggi, G. Mauro Cattaneo, C. Cozzarini, N. Di Muzio, E. Maggiulli, P. Mangili, L. Perna, R. Valdagni, F. Fazio, R. Calandrino
Prostate cancer treatment in Europe at the end of 1990s
2009 G. Gatta, G. Zigon, A. Buemi, J. Coebergh, M. Colonna, P. Contiero, L. Denis, P. Grosclaude, A. Guizard, M. Sanchez-Perez, I. Plesko, M. Ondrusova, J. Rachtan, R. Valdagni, M. Velten, M. Vercelli, F. Berrino
Predictive Modeling in Prostate Cancer : a Conference Summary
2009 R. Valdagni, P. Scardino, L. Denis, M. Kattan
miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase C epsilon
2009 P. Gandellini, M. Folini, N. Longoni, M. Pennati, M. Binda, M. Colecchia, R. Salvioni, R. Supino, R.M. Moretti, P. Limonta, R. Valdagni, M.G. Daidone, N. Zaffaroni
Quality assurance of 3D-CRT : indications and difficulties in their applications
2009 L. Begnozzi, M. Benassi, M. Bertanelli, A. Bonini, L. Cionini, L. Conte, C. Fiorino, P. Gabriele, G. Gardani, A. Giani, S. Magri, M. Morelli, B. Morrica, P. Olmi, R. Orecchia, G. Penduzzu, L. Raffaele, A. Rosi, M.A. Tabocchini, R. Valdagni, V. Viti
Phase I-II Study of Hypofractionated Simultaneous Integrated Boost With Tomotherapy for Prostate Cancer
2009 N. Di Muzio, C. Fiorino, C. Cozzarini, F. Alongi, S. Broggi, P. Mangili, G. Guazzoni, R. Valdagni, R. Calandrino, F. Fazio
The 2008 European School of Oncology Inside Track Conference, "Predictive Modeling in Prostate Cancer"
2009 R. Valdagni, P.T. Scardino, L. Denis
Modified peptides in anti-cancer vaccines: Are we eventually improving anti-tumour immunity?
2009 M. Iero, P. Filipazzi, C. Castelli, F. Belli, R. Valdagni, G. Parmiani, R. Patuzzo, M. Santinami, L. Rivoltini
Predictive models of toxicity in external radiotherapy : dosimetric issues
2009 C. Fiorino, T. Rancati, R. Valdagni
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile